Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1

1(33.3%)

N/A

1(33.3%)

Phase 2

1(33.3%)

3Total

Phase 1(1)

N/A(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04517422Not ApplicableCompleted

Efficacy of L. Plantarum and P. Acidilactici in Adults With SARS-CoV-2 and COVID-19

Role: collaborator

NCT04661969Completed

"Outcomes of Surgical Removal of Foreign Body Granulomas"

Role: lead

NCT04584723Completed

Microsurgery in the Elderly in a Private Practice Setting

Role: lead

NCT04588493Completed

Secondary Lymphedema Due to Human Adjuvant Disease

Role: lead

NCT04579744Completed

Postoperative Quality of Life in Treated Patients With Human Adjuvant Disease

Role: lead

NCT02780895Phase 1Unknown

Parkinsonian Brain Repair Using Human Stem Cells

Role: collaborator

NCT01379820Phase 2Unknown

Use of Orotracheal Continuous Positive Airway Pressure (CPAP) in Newborns With Respiratory Failure

Role: lead

All 7 trials loaded